Skip to main content
  • Published:

The Effect of Carbon Tetrachloride (CCl4) Induced Liver Damage on the Volume of Distribution, the Elimination Half-Life and body Clearance of Antipyrine and Warfarin in Rabbits

Virkningen af tetraklorkulstof (CCl4) induceret leverbeskadigelse på fordelingsvolumen, halveringstid og body clearance af antipyrin og warfarin hos kaniner

Abstract

The pharmacokinetics of antipyrine and warfarin were investigated in rabbits with carbon tetrachloride (CCl4) induced liver damage. The volume of distribution of antipyrine was slightly increased whereas it was markedly reduced for warfarin when estimated 24 h after the CCl4 injection. Twenty-four h after the CCl4 injection, the elimination rate constant, the half-life and the body clearance were significantly changed for both compounds. The effect of CCl4 on the pharmacokinetic parameters of antipyrine persisted 10 days after the CCl4 injection, whereas the pharmacokinetic parameters of warfarin were normalized at that time. The clinical importance of the changes of drug pharmacokinetics in liver diseases is mentioned, and it is concluded that each drug may behave differently, so that a drug has to be investigated separately in every disease for which the drug is prescribed.

Sammendrag

Fordelingsvolumen, eliminationskonstant, halveringstid og body clearance for antipyrin og warfarin blev bestemt hos normale kaniner og hos de samme kaniner 24 timer og 10 dage efter injektion af tetra-klorkulstof (GG14) 0,4 ml/kg lgv. eller 0,2 ml/kg Igv. Fordelingsvolu-menet for antipyrin var større hos kaninerne 24 timer efter GC14 injektionen, og ændringen kunne stadig påvises 10 dage efter GG14 injektionen. Warfarins fordelingsvolumen var signifikant mindre hos kaninerne 24 timer efter GG14 injektionen sammenlignet med kontrolværdien, men 10 dage efter GG14 infektionen var fordelingsvolumenet igen normaliseret. Eliminationskon & tanten, halveringstiden og body clearance for både antipyrin og warfarin ændredes signifikant 24 timer efter GG14 injektionen. Kun for antipyrin kunne der påvises ændringer i de tre parametre 10 dage efter injektionen.

Den kliniske betydning af ændringer i lægemidlers farmakokinetik ved leversygdomme påpeges. Mulighederne for at anvende CG14 inducerede leverskader som model ved studier af farmakokinetiske konstanter ved leversygdomme i veterinærmedicinen fremhæves.

References

  • Alfieri-Rolla, G. & G. Segre: The effect of carbon tetrachloride on the kinetics of bromsulphalein clearance in the rabbit. Europ. J. Pharmacol. 1968, 3, 330–336.

    Article  CAS  Google Scholar 

  • Brodie, B. B., J. Axelrod, R. Soberman & B. B. Levy: The estimation of antipyrine in biological materials. J. biol. Chem. 1949, 179, 25–29.

    CAS  PubMed  Google Scholar 

  • Corn, M. & R. Berberich: Rapid fluorometric assay for plasma warfarin. Clin. Chem. 1967, 13, 126–131.

    Article  CAS  Google Scholar 

  • Kato, R.: Drug metabolism under pathological and abnormal physiological states in animals and man. Xenobiotica 1977, 7, 25–92.

  • Klotz, U.: Influence of liver disease on the elimination of drugs. Europ. J. Drug Metab. Pharmacokinetics 1976a, 3, 129–140.

  • Klotz, U.: Pathophysiological and disease-induced changes in drug distribution volume: Pharmacokinetic implication. Clin. Pharmacokin. 1976 b, 1, 204–218.

  • Kunii, O., K. Fukaya & K. Mashimo: Biotransformation of the antibiotics in the patients and animals with liver impairment. Chemotherapy 1975, 4, 159–164.

    Google Scholar 

  • Ladefoged, O.: Absorptionen fra peritonealhulen, Eksperimentelle undersøgelser over intraperitonealt applicerede la3gemidlers farmakokinetik. (Absorption from the peritoneal cavity). Ph. D. Thesis, Copenhagen 1975, 79 pp.

  • Ladefoged, O.: Endotoxin induced changes in the pharmacokinetics of warfarin in rabbits. Acta vet. scand. 1978, 19, 479–486.

    CAS  PubMed  Google Scholar 

  • Pessayre, D., H. Allemand & J. P. Benhamou: Effets des maladies du foi et des voies biliaires sur le metabolisme des médicaments. (Effects of hepato-biliary diseases on drug metabolism). Nouv. Press, med, 1977, 6, 3209–3219.

    CAS  Google Scholar 

  • Shand, D. G.: Drug disposition in liver disease. New Engl. J. Med. 1977, 296, 1527–1528,

  • Siegers, C. P., O. Strubelt & A. Schütt: Relations between hepatotoxicity and pharmacokinetics of paracetamol in rats and mice. Pharmacology 1978, 16, 273–278.

    Article  CAS  Google Scholar 

  • Wilkinson, G. R. & S. Schenker: Drug disposition and liver disease. Drug Metabol. Rev. 1975, 4, 139–175.

    Article  CAS  Google Scholar 

  • Wilkinson, G. R. & S. Schenker: Effects of liver disease on drug disposition in man. Riochem. Pharmacol. 1976, 25, 2675–2681.

    Article  CAS  Google Scholar 

  • Willson, R. A. & F. E. Hart: Effect of experimental hepatic injury on in vitro drugmetabolizing enzyme activities in the rat. Gastroenterology 1977, 73, 691–696.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The work was supported by the Danish Agricultural and Veterinary Research Council.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ladefoged, O. The Effect of Carbon Tetrachloride (CCl4) Induced Liver Damage on the Volume of Distribution, the Elimination Half-Life and body Clearance of Antipyrine and Warfarin in Rabbits. Acta Vet Scand 20, 429–437 (1979). https://doi.org/10.1186/BF03546604

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1186/BF03546604

Keywords